EndoCyclic Therapeutics, a biopharmaceutical company developing precision peptide therapeutics and diagnostics for complex diseases, today announced that the U.S. Food and Drug Administration (FDA) ...
Kärnfull Next has submitted an application to build a power plant based on small modular reactors in the municipality of ...
Fractyl Health announced a first-in-human trial for RJVA-001, targeting T2D and obesity, pending regulatory approval by 2026. Fractyl Health, Inc. has announced the submission of the first module of ...
It’s been over a decade since the first application for a spot bitcoin ETF was filed. After a number of denials over the years, the U.S. Securities and Exchange Commission has approved all 11 ...
TMC is uniquely positioned having completed the requisite resource, environmental, engineering and processing work to begin commercial recovery activities. · GlobeNewswire Inc. First application under ...